Efficacy of Topical 5% Imiquimod Cream for the Treatment of Nodular Basal Cell Carcinoma
Top Cited Papers
- 1 September 2002
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 138 (9) , 1165-1171
- https://doi.org/10.1001/archderm.138.9.1165
Abstract
Research from JAMA Dermatology — Efficacy of Topical 5% Imiquimod Cream for the Treatment of Nodular Basal Cell Carcinoma — Comparison of Dosing RegimensKeywords
This publication has 5 references indexed in Scilit:
- Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trialJournal of the American Academy of Dermatology, 2001
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% creamJournal of the American Academy of Dermatology, 1999
- Differences in Age, Site Distribution, and Sex Between Nodular and Superficial Basal Cell Carcinomas Indicate Different Types of TumorsJournal of Investigative Dermatology, 1998
- Cytokine induction by the immunomodulators imiquimod and S-27609Journal of Leukocyte Biology, 1995
- Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infectionAntiviral Research, 1988